Dr. Ted Love is chief executive officer of the San Francisco biotech company Nuvelo. He was appointed to his position in in 2001 after previously holding several senior management positions in medical affairs and product development at the well-known biotech company Genentech. At Genentech, he oversaw many drugs in development including the breast cancer treatment Herceptin. Dr. Love earned his bachelor's degree in molecular biology from Haverford College in Haverford, Pennsylvania, and his medical degree at the Yale School of Medicine. He completed his residency and fellowship training in internal medicine and cardiology at Massachusetts General Hospital and Harvard Medical School.